BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Business

  Auriga Laboratories, Inc. Reports Record 2007 First Quarter Financial Results

  April 16, 2007

   · 

  1 min read
• Business

  Applied Biosystems and Celera Genomics Group-an Applera Corp. Business Third Quarter Fiscal 2007 Financial Results and Conference Call Scheduled for April 26, 2007

  April 16, 2007

   · 

  1 min read
• Drug Development

  ZIOPHARM Oncology, Inc. Presents Unique Mechanism Data for Indibulin at American Association for Cancer Research

  April 16, 2007

   · 

  1 min read
• Elekta AB Initiatives Will Increase Access to Gamma Knife(R) Surgery, the Gold Standard in Radiosurgery

  April 16, 2007

   · 

  1 min read
• Biotech Beach

  Somanta Pharmaceuticals, Inc. Announces the Presentation of Alchemix Data at The American Association for Cancer Research Annual Meeting

  April 16, 2007

   · 

  1 min read
• Biotech Beach

  BioImagene, Inc. Introduces TissueMine(TM) 1.8 -- A Total Digital Pathology Solution for BioPharma R&D

  April 16, 2007

   · 

  1 min read
• ARIUS Research Inc. to Present at American Association for Cancer Research Annual Meeting

  April 16, 2007

   · 

  1 min read
• Business

  Prasco Laboratories and Graceway Pharmaceuticals, LLC Sign a Distribution and Supply Agreement for Authorized Generic Version of MetroGel-Vaginal Gel (metronidazole vaginal gel 0.75%)

  April 16, 2007

   · 

  1 min read
• Pharm Country

  Thomas Pharmaceuticals Files Registration Statement with SEC in Anticipation of Spin Off by iVoice, Inc. to its Shareholders

  April 16, 2007

   · 

  1 min read
• Drug Development

  Data Presented at American Association for Cancer Research Meeting Shows Peregrine Pharmaceuticals, Inc.'s Selective Anti-VEGF Antibodies are as Effective as Avastin(R) in Preclinical Cancer Models

  April 16, 2007

   · 

  1 min read